Cemiplimab in advanced BCC

FDA D.I.S.C.O. Burst Edition: Libtayo (cemiplimab-rwlc) for patients with locally advanced or met...Подробнее

(Dr HA) FDA Approves LIBTAYO (Cemiplimab) for Advanced Basal Cell Carcinoma / Bs Võ Hoàng AnhПодробнее

LIBTAYO (cemiplimab-rwlc)- Squamous Cell Carcinoma- Basal Cell Carcinoma- Non small Lung CancerПодробнее

New Treatments in Melanoma and Non-Melanoma​ Skin CancerПодробнее

Vulvar cancerПодробнее

Dr. Atlas on the Rationale for Cemiplimab in Locally Advanced CSCCПодробнее

Dr. Stratigos the Rationale to Evaluate Cemiplimab in Locally Advanced BCCПодробнее